Key Record Dates
ClinicalTrials.gov Identifier: | NCT03180840 |
---|---|
Brief Title: | Study of the Safety, Efficacy, & PK of Pegunigalsidase Alfa (PRX-102) 2 mg/kg IV Administered Every 4 Weeks in Fabry Disease Patients (BRIGHT) |
First Submitted : | May 29, 2017 |
First Submitted that Met QC Criteria : | June 7, 2017 |
First Posted : | June 8, 2017 |
Last Update Submitted that Met QC Criteria : | September 25, 2019 |
Last Update Posted : | September 26, 2019 |